CAV chemotherapy (CCNU, melphalan, etoposide) as salvage treatment for relapsing or resistant Hodgkin's disease

E. Brusamolino, G. Castelli, G. Pagnucco, E. Orlandi, D. Malago, M. Lazzarino, C. Bernasconi

Research output: Contribution to journal › Article › peer-review

ASJC Scopus subject areas

@article{d2ae649d1f0645049f1ebe118d24df4d,

title = "CAV chemotherapy (CCNU, melphalan, etoposide) as salvage treatment for relapsing or resistant Hodgkin's disease",

author = "E. Brusamolino and G. Castelli and G. Pagnucco and E. Orlandi and D. Malago and M. Lazzarino and C. Bernasconi",

year = "1990",

language = "English",

volume = "75",

pages = "340--345",

journal = "Haematologica",

issn = "0390-6078",

publisher = "NLM (Medline)",

number = "4",

}

TY - JOUR

T1 - CAV chemotherapy (CCNU, melphalan, etoposide) as salvage treatment for relapsing or resistant Hodgkin's disease

AU - Brusamolino, E.

AU - Castelli, G.

AU - Pagnucco, G.

AU - Orlandi, E.

AU - Malago, D.

AU - Lazzarino, M.

AU - Bernasconi, C.

PY - 1990

Y1 - 1990

UR - http://www.scopus.com/inward/record.url?scp=0025011039&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0025011039&partnerID=8YFLogxK

M3 - Article

C2 - 1703510

AN - SCOPUS:0025011039

VL - 75

SP - 340

EP - 345

JO - Haematologica

JF - Haematologica

SN - 0390-6078

IS - 4

ER -